Word: clear
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...year, but there are fewer big deals to find - the 75% to 80% markdowns seen during last year's holiday season are now rare. Retailers purchased up to 20% less inventory this year in anticipation of slower sales, so they're not under the gun to slash prices to clear inventory - at least...
...Even if the final tally indicates sales surpassed last year's numbers, it's not necessarily clear sailing for retailers through the holiday season. The average shopper spent $372 over the Black Friday weekend last year, which was up from $347 the previous year, says Grannis. Yet, holiday sales, which tracks total sales through November and December, fell 3.4% - the first decline since the NRF started tracking sales in the mid-1990s, she says...
...September, researchers at the University of Washington reported in the journal Nature that they had produced color vision in squirrel monkeys, which are normally born colorblind. Using a tiny syringe, researchers injected the single missing gene for color vision into the monkeys' eyes. The result was clear: monkeys that previously could not distinguish red, green and gray were easily able to pass a simian equivalent of a color-detection test. (See the top 10 medical breakthroughs...
...French children with a rare genetic immune disorder developed leukemia after they received gene-therapy injections containing retroviruses. The other 18 children in the trial were cured, but the setback reverberated through the field, dissuading researchers and funding. "A lot of financial interest has disappeared since it became clear that it's going to take a long time and it's not going to be easy [to develop gene-therapy drugs]," says Hank Greely of Stanford University's Center for Biomedical Ethics...
...Many believe that over the next four to five years, they will be able to apply what they have learned from studying gene therapies for rare diseases to the treatment of more common ailments like epilepsy, arthritis and congestive heart failure. "[Gene therapy] still needs one killer app. One clear, unambiguous success," says Greely. "And then the money will flood...